http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2063381-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_601aea756a699025b0af6f88c48fe4bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24beed2ee11f430ab3acb1e6a1f85668 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 1988-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ee5369bbfba3544a06e67a74a5b429a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfabb877168297f9e59fcd1ccfc8e6e7 |
| publicationDate | 1996-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2063381-C1 |
| titleOfInvention | Process for determining exacerbation of diffusion liver disease |
| abstract | FIELD: medicine. SUBSTANCE: process comprises sampling 1 ml of blood serum, pouring 0.5 ml of 10% trichloroacetic acid thereto, centrifuging the whole at 3000 rpm for 30 minutes, separating supernatant liquid, diluting it with distilled water at 1:9 ratio and subjecting the mixture to spectrophotometry at wavelength of 280 nm, and at value of 0.355 or more, determining exacerbation of diffusion liver disease. EFFECT: more accurate early diagnostics of active phase. |
| priorityDate | 1988-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.